Clinical Trial Update: A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia.. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the analgesic efficacy of AZD2423 vs placebo after 28 days of treatment in patients with posttraumatic neuralgia; results were posted o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Neuralgia

Drugs mentioned

• AZD2423

Snippet

Sponsor: AstraZeneca | Conditions: Nerve Pain | Phase 2 | Status: COMPLETED | Results posted: 2013-09-25